Danaher's quarterly results show signs of life, and the stock in difficulties is triggered
Danaher's actions rose more than 6% on Tuesday after the results of the first quarter of the medical care company…
Jim Cramer
We are lowering our target price of Bristol Myers despite a profit rate
Bristol Myers Squibb and Rosy Outlook's profits on Thursday did not solve persistent problems for actions. But it was enough,…
These are the 4 greatest things we are seeing in the stock market next week.
The stock market is directed to Monday with a volatility streak, it seems that it cannot be shaken. What had…
Eli Lilly shares the increase in the new data of the obesity pill. What means for the actions of here
Eli Lilly is pressing the lucrative weight loss market as it advances to a new and more convenient phase that…
Abbott Labs shares an increase in profits and a great sign of confidence in the business
ABBOTT Laboratories actions jumped on Wednesday after the diversified medical care company delivered strong results of the first quarter and…
Apple recovers with the market, the analyst divided into our drug stock
Every day of the week, the CNBC Investing Club with Jim Cramer has a live broadcast of the “morning meeting”…
We are leaving our position in a medical care action to raise some cash.
Shortly after the opening bell, we will leave our position in Ge Healthcare, selling 550 shares at approximately $ 65.…
Do not ignore the impact of pharmaceutical rates, says an analyst. Where we stop in Bristol Myers
The drug stock is higher during the past month, while the S&P 500 has retired sharply.
We are buying more shares of 2 shares as the broader market sinks more
We are doing our first exchanges of the week. We are buying 25 shares from Danaher to approximately $ 207…
2 portfolio actions that should benefit from an impulse in the spending of major Americans
Home Depot and Ge Healthcare are the companies that Mizuho believes that he will receive an impulse from an American…